Berberine Attenuates Axonal Transport Impairment and Axonopathy Induced by Calyculin A in N2a Cells

Berberine is a primary component of the most functional extracts of Coptidis rhizome used in traditional Chinese medicine for centuries. Recent reports indicate that Berberine has the potential to prevent and treat Alzheimer's disease (AD). The previous studies reported that Calyculin A (CA) impaired the axonal transport in neuroblastoma-2a (N2a) cells. Berberine attenuated tau hyperphosphorylation and cytotoxicity induced by CA. Our study aimed at investigating the effects of Berberine on the axonal transport impairment induced by CA in N2a cells. The results showed that Berberine could protect the cell from CA -induced toxicity in metabolism and viability, as well as hyperphosphorylation of tau and neurofilaments (NFs). Furthermore, Berberine could reverse CA-induced axonal transport impairment significantly. Berberine also partially reversed the phosphorylation of the catalytic subunit of PP-2A at Tyrosine 307, a crucial site negatively regulating the activity of PP-2A, and reduced the levels of malondialdehyde and the activity of superoxide dismutase, markers of oxidative stress, induced by CA. The present work for the first time demonstrates that Berberine may play a role in protecting against CA-induced axonal transport impairment by modulating the activity of PP-2A and oxidative stress. Our findings also suggest that Berberine may be a potential therapeutic drug for AD.

[1]  I. Grundke‐Iqbal,et al.  The regulation of phosphorylation of τ in SY5Y neuroblastoma cells: the role of protein phosphatases , 1998, FEBS letters.

[2]  S. Marklund,et al.  Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. , 1974, European journal of biochemistry.

[3]  I. Grundke‐Iqbal,et al.  Phosphoprotein Phosphatase Activities in Alzheimer Disease Brain , 1993, Journal of neurochemistry.

[4]  Jian-Zhi Wang,et al.  Alzheimer-like tau phosphorylation induced by wortmannin in vivo and its attenuation by melatonin. , 2002, Acta pharmacologica Sinica.

[5]  G. Benítez-King,et al.  Melatonin prevents cytoskeletal alterations and oxidative stress induced by okadaic acid in n1e-115 cells , 2003, Experimental Neurology.

[6]  D. Hartshorne,et al.  Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. , 1989, Biochemical and biophysical research communications.

[7]  Q. Tian,et al.  Inhibition of protein phosphatases induces transport deficits and axonopathy , 2007, Journal of neurochemistry.

[8]  M. Smith,et al.  Neurofilament proteins in neurodegenerative diseases , 2004, Cellular and Molecular Life Sciences CMLS.

[9]  R. Liu,et al.  Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats , 2003, Neuroscience.

[10]  George Perry,et al.  Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. , 2003, The American journal of pathology.

[11]  I. Grundke‐Iqbal,et al.  Tau pathology in Alzheimer disease and other tauopathies. , 2005, Biochimica et biophysica acta.

[12]  F. Ruddle,et al.  Isolation of microtubule protein from cultured mouse neuroblastoma cells. , 1970, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Nitsch,et al.  Reduced protein phosphatase 2A activity induces hyperphosphorylation and altered compartmentalization of tau in transgenic mice. , 2001, The Journal of biological chemistry.

[14]  B. Picconi,et al.  Protein phosphatase inhibitors induce modification of synapse structure and tau hyperphosphorylation in cultured rat hippocampal neurons , 1997, Journal of neuroscience research.

[15]  Youmei Feng,et al.  Increased expression of cdk5/p25 in N2a cells leads to hyperphosphorylation and impaired axonal transport of neurofilament proteins. , 2010, Life sciences.

[16]  E. Masliah,et al.  Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease , 2005, Science.

[17]  Jian-Zhi Wang,et al.  Melatonin protects SH‐SY5Y neuroblastoma cells from calyculin A‐induced neurofilament impairment and neurotoxicity , 2004, Journal of pineal research.

[18]  N. Bajaj.  Cyclin-dependent kinase-5 (CDK5) and amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[19]  Huachun Sang,et al.  Phosphorylation of tau by glycogen synthase kinase 3β in intact mammalian cells influences the stability of microtubules , 2001, Neuroscience Letters.

[20]  H. Wiśniewski,et al.  Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Juan Chen,et al.  Melatonin reduces the impairment of axonal transport and axonopathy induced by calyculin A , 2011, Journal of pineal research.

[22]  Q. Tian,et al.  Berberine attenuates calyculin A-induced cytotoxicity and Tau hyperphosphorylation in HEK293 cells. , 2011, Journal of Alzheimer's disease : JAD.

[23]  H. Kobe,et al.  Effect of regular maternal exercise on lipid peroxidation levels and antioxidant enzymatic activities before and after delivery. , 2002, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[24]  R. Reiter,et al.  Melatonin Prevents Death of Neuroblastoma Cells Exposed to the Alzheimer Amyloid Peptide , 1997, The Journal of Neuroscience.

[25]  J. Trojanowski,et al.  A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. , 1991, Science.

[26]  P. Greengard,et al.  Gleevec inhibits beta-amyloid production but not Notch cleavage. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Sangmook Lee,et al.  Hypophosphorylated neurofilament subunits undergo axonal transport more rapidly than more extensively phosphorylated subunits in situ. , 2000, Cell motility and the cytoskeleton.

[28]  E. Mandelkow,et al.  Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding , 1993, Neuron.

[29]  T. Saido,et al.  Berberine alters the processing of Alzheimer's amyloid precursor protein to decrease Abeta secretion. , 2007, Biochemical and biophysical research communications.

[30]  Khadija Iqbal,et al.  Inhibition of PP‐2A upregulates CaMKII in rat forebrain and induces hyperphosphorylation of tau at Ser 262/356 , 2001, FEBS letters.

[31]  R. Liem.  Neuronal intermediate filaments. , 1990, Current opinion in cell biology.

[32]  T B Shea,et al.  Phospho-dependent association of neurofilament proteins with kinesin in situ. , 2000, Cell motility and the cytoskeleton.

[33]  C. Shaw,et al.  Glutamate Slows Axonal Transport of Neurofilaments in Transfected Neurons , 2000, The Journal of cell biology.

[34]  T. Shea,et al.  C-terminal phosphorylation of the high molecular weight neurofilament subunit correlates with decreased neurofilament axonal transport velocity , 2000, Brain Research.

[35]  Q. Tian,et al.  Melatonin ameliorates Alzheimer-like pathological changes and spatial memory retention impairment induced by calyculin A , 2010, Alzheimer's & Dementia.

[36]  K. Iqbal,et al.  Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine. , 2006, FEBS letters.

[37]  Jian-Zhi Wang,et al.  Melatonin attenuates isoproterenol‐induced protein kinase A overactivation and tau hyperphosphorylation in rat brain , 2004, Journal of pineal research.

[38]  D. Price,et al.  High Molecular Weight Neurofilament Proteins Are Physiological Substrates of Adduction by the Lipid Peroxidation Product Hydroxynonenal* , 2002, The Journal of Biological Chemistry.

[39]  A. Grierson,et al.  Axonal transport of neurofilaments in normal and disease states , 2002, Cellular and Molecular Life Sciences CMLS.

[40]  F. Ebner,et al.  Protein serine/threonine phosphatase 1 and 2A associate with and dephosphorylate neurofilaments. , 1997, Brain research. Molecular brain research.

[41]  Feiqi Zhu,et al.  Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease , 2006, BMC Neuroscience.

[42]  J. Brion,et al.  Accumulation of smooth endoplasmic reticulum in Alzheimer's disease: new morphological evidence of axoplasmic flow disturbances. , 1989, Journal of submicroscopic cytology and pathology.

[43]  P. Kakkar,et al.  Antihyperglycemic and antioxidant effect of Berberis aristata root extract and its role in regulating carbohydrate metabolism in diabetic rats. , 2009, Journal of ethnopharmacology.

[44]  I. Grundke‐Iqbal,et al.  Restoration of biological activity of Alzheimer abnormally phosphorylated tau by dephosphorylation with protein phosphatase-2A, -2B and -1. , 1996, Brain research. Molecular brain research.

[45]  K. Bae,et al.  Cholinesterase inhibitory and anti-amnesic activity of alkaloids from Corydalis turtschaninovii. , 2008, Journal of ethnopharmacology.

[46]  T. Arendt,et al.  Phosphorylation of Tau, Aβ-Formation, and Apoptosis After In Vivo Inhibition of PP-1 and PP-2A , 1998, Neurobiology of Aging.